Galatea Bio logo

Galatea Bio Funding & Investors

Hialeah, FL

Galatea Bio, a US-based biotechnology company was founder by Carlos Bustamante, Nicholas Katsanis and Alexander Ioannidis. Our mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research. We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests, treatments, and cures that will improve the lives of all.

galatea.bio

Total Amount Raised: $28,656,000

Galatea Bio's Investors

Galatea Bio Funding Rounds

  • Series Unknown

    $8,000,000

    Series Unknown Investors

    F-Prime Capital
    CEI Ventures
    Alexandria Real Estate Equities
    Digitalis Ventures
    AME Cloud Ventures
    Founder Collective
    HBM Genomics
    Helios Investment Partners
    Leland Stanford Junior University
    Alix Ventures
    Chan Zuckerberg Biohub
    Citta Capital
  • Debt Financing

    $3,656,000

  • Series A

    $10,000,000

  • Seed

    $7,000,000

    Seed Investors

    Digitalis Ventures
    F-Prime Capital
    Edward Lando
    Pareto Holdings
Funding info provided by Diffbot.